Abstract:The CRISPR system, as an effective genome editing technology, has been extensively utilized for the construction of disease models in human pluripotent stem cells. Establishment of a gene mutant or knockout stem cell line typically relies on Cas nuclease-generated double-stranded DNA breaks and exogenous templates, which can produce uncontrollable editing byproducts and toxicity. The recently developed adenine base editors (ABE) have greatly facilitated related research by introducing A/T > G/C mutations in the coding regions or splitting sites (AG-GT) of genes, enabling mutant gene knock-in or knock-out without introducing DNA breaks. In this study, we edit the AG bases in exons anterior to achieve gene knockout via the ABE8e-SpRY, which recognizes most expanded protospacer adjacent motif to target the genome. Except for gene-knockout, ABE8e-SpRY can also efficiently establish disease-related A/T-to-G/C variation cell lines by targeting coding sequences. The method we generated is simple and time-saving, and it only takes two weeks to obtain the desired cell line. This protocol provides operating instructions step-by-step for constructing knockout and point mutation cell lines.

Generation of a TRPV1 Knockout Human Pluripotent Stem Cell Line (Wae009-a-u) Using CRISPR/Cas9.

Generation of a Lamin A/C Knockout Human Induced Pluripotent Stem Cell Line (Zjulli007-A) Via CRISPR/Cas9

Generation of an ELTD1 knockout human embryonic stem cell line by the iCRISPR/Cas9 system

Generation of a homozygous (MCRIi031-A-3) WT1 knockout human iPSC line

Generation of ID1/3 knockout human embryonic stem cell lines (WAe009-A-2A and WAe009-A-2B) derived from H9 using CRISPR/Cas9

Engineering Human Stem Cell Lines with Inducible Gene Knockout Using CRISPR/Cas9

Generation of a Bag1 Homozygous Knockout Mouse Embryonic Stem Cell Line Using CRISPR/Cas9.

Generation of a ISL1 homozygous knockout stem cell line (WAe009-A-1G) by episomal vector-based CRISPR/Cas9 system

Generation of a PPM1A -deficient human induced pluripotent stem cell line using CRISPR-Cas9 technology

Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9

Generation of a TMEM43 knockout human induced pluripotent stem cell line (HDZi003-A-1) using CRISPR/Cas9

Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing

An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells

Generation of a TSC2 knockout embryonic stem cell line by CRISPR/Cas9 editing

Crispr-Based Editing of Human Pluripotent Stem Cells for Disease Modeling

Establishment of human embryonic stem cell lines carrying LQT1 mutations by CRISPR base editing

Generation of a homozygous DNAJC19 knockout human embryonic stem cell line by CRISPR/Cas9 system

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Efficient CRISPR/Cas9-Mediated Versatile, Predictable, and Donor-Free Gene Knockout in Human Pluripotent Stem Cells.

Generation of a CAG-EGFP tagged cell line (KSCBi017-A-2) from human induced pluripotent stem cells using CRISPR/Cas9

Small Molecules Promote CRISPR-Cpf1-mediated Genome Editing in Human Pluripotent Stem Cells